达刚控股(300103) - 2022 Q3 - 季度财报

Financial Performance - Revenue for Q3 2022 was ¥102,456,023.84, a decrease of 43.73% year-over-year, and total revenue for the year-to-date was ¥276,051,113.20, down 56.54% compared to the same period last year[3] - Net loss attributable to shareholders for Q3 2022 was ¥270,411,642.71, representing a staggering increase of 7,916.75% year-over-year, with a year-to-date net loss of ¥283,655,890.03, up 1,452.10%[3] - Basic and diluted earnings per share for Q3 2022 were both -¥0.8514, reflecting a decline of 7,911.19% year-over-year[3] - Operating revenue for the current period was CNY 276,051,113.20, down 56.52% from CNY 635,211,570.96 in the previous period[24] - The company reported a net loss from investments of CNY 459,017.84, compared to a loss of CNY 642,225.92 in the previous period[24] - The company reported a total comprehensive income of -313,701,500.68 CNY for Q3 2022, compared to 36,180,643.21 CNY in Q3 2021[25] - The total operating profit was -317,728,752.97 CNY, compared to a profit of 37,239,071.39 CNY in Q3 2021[25] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥1,815,786,309.26, a decrease of 18.94% from the end of the previous year[3] - As of September 30, 2022, total current assets amounted to CNY 989,148,817.42, a decrease of 18.73% from CNY 1,217,752,116.04 at the beginning of the year[20] - The total liabilities decreased from CNY 868,880,065.41 to CNY 755,308,858.48, reflecting a reduction of approximately 13.06%[21] - The total equity attributable to shareholders decreased from CNY 1,073,583,550.02 to CNY 789,369,560.63, a decline of approximately 26.5%[22] - The company’s long-term borrowings increased from CNY 139,405,545.83 to CNY 176,310,000.00, an increase of 26.5%[21] - The total liabilities increased, leading to a higher financial burden on the company, although specific figures were not disclosed in the report[29] Cash Flow - Cash flow from operating activities for the year-to-date was ¥78,616,704.15, down 65.13% compared to the same period last year[3] - The cash flow from operating activities showed a net inflow of 78,616,704.15 CNY, compared to 225,426,676.00 CNY in the previous year, reflecting a decline of about 65.1%[27] - The company had a net cash outflow from investing activities of 76,128,950.45 CNY, contrasting with a net outflow of -171,790,134.30 CNY in the previous year[28] - The company’s cash and cash equivalents increased to CNY 116,962,546.79 from CNY 82,095,860.46, representing a growth of 42.5%[19] - The cash and cash equivalents at the end of the period were 115,115,553.13 CNY, a decrease from 134,366,189.21 CNY at the end of the previous year[28] Shareholder Information - The total number of common shareholders at the end of the reporting period is 11,802[9] - The largest shareholder, Sun Jianxi, holds 26.65% of the shares, totaling 84,641,584 shares, with 63,481,188 shares pledged[10] - The second-largest shareholder, Yingqi Investment (Hangzhou) Co., Ltd., holds 19.90% of the shares, totaling 63,202,590 shares[10] - The company has a total of 72,177,524 restricted shares at the end of the reporting period, with no shares released during the current period[12] - A major shareholder, Shenzhen Lingtong Biotechnology Co., Ltd., plans to reduce its holdings by up to 9,520,000 shares, approximately 3% of the total share capital[16] Operational Changes - Research and development expenses for Q3 2022 were ¥15,041,258.73, a decrease of 45.99% due to reduced logistics efficiency caused by the pandemic[8] - Research and development expenses were CNY 15,041,258.73, down 46.06% from CNY 27,850,962.20 in the previous period[24] - The company reported a significant increase in short-term borrowings, which rose by 204.76% to ¥73,774,000.00, used for operational activities[7] - Contract liabilities increased by 74.01% to ¥66,620,511.53, attributed to an increase in advance payments from sales contracts[8] - The company recorded a loss from asset disposal of ¥2,253,949.68, a decrease of 2,680.29% compared to the previous period[8] - The net cash increase for the period was ¥52,167,750.38, a 216.82% increase due to reduced procurement payments and debt repayments[8] - The company plans to establish a wholly-owned subsidiary, Dagang Environment (Hubei), with an investment of 5 million RMB to expand its business in pest control and rural revitalization[14] - The company is in the process of terminating and deregistering Dagang New Materials Company to optimize resource allocation and reduce investment risks[15] - The company incurred an asset impairment loss of 272,817,166.35 CNY during the quarter[25]